|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-7-15
|
|
pubmed:abstractText |
Interleukin-12 (IL-12) is a cytokine with potent antitumor effects. The authors sought to assess its capacity to increase tumor immunogenicity when expressed by tumor cells in a murine model of neuroblastoma.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-3468
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
902-6; discussion 906-7
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10359203-Adenoviridae,
pubmed-meshheading:10359203-Adjuvants, Immunologic,
pubmed-meshheading:10359203-Animals,
pubmed-meshheading:10359203-Cytotoxicity, Immunologic,
pubmed-meshheading:10359203-Gene Therapy,
pubmed-meshheading:10359203-Genetic Vectors,
pubmed-meshheading:10359203-Immunohistochemistry,
pubmed-meshheading:10359203-Immunotherapy,
pubmed-meshheading:10359203-Interleukin-12,
pubmed-meshheading:10359203-Mice,
pubmed-meshheading:10359203-Neuroblastoma,
pubmed-meshheading:10359203-Remission Induction,
pubmed-meshheading:10359203-Transduction, Genetic,
pubmed-meshheading:10359203-Tumor Cells, Cultured
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Neuroblastoma regression and immunity induced by transgenic expression of interleukin-12.
|
|
pubmed:affiliation |
Department of Surgery, St Jude Children's Research Hospital and University of Tennessee, Memphis 38105, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
